A series of molecules that provide reliable cure with fewer side effects to people having autoimmune diseases were developed by the team of researchers in Purdue University.
Living with an autoimmune disease can feel like an insider is attacking your body. An estimated 24 million people in the United States are affected by autoimmune diseases, a group of diseases in which the person's immune system attacks part of the person's own body.
Autoimmune Inner Ear Disease
Autoimmune inner ear disease is a condition that causes progressive deterioration of hearing and hearing loss. This is a serious condition that needs prompt medical attention.
Advertisement
‘The newly discovered molecules are an appropriate form of Janus Kinase inhibitors that provide relief in autoimmune diseases such as rheumatoid arthritis, psoriasis and myelofibrosis with fewer side effects.’
Tweet it Now
The new inhibitors may provide relief for people suffering from rheumatoid arthritis, psoriasis, myelofibrosis and other autoimmune diseases with a reduction in side effects compared with current therapies. The research appears in the November edition of the Journal of Medicinal Chemistry.
"Our new molecules fit within the emerging field of therapeutically useful Janus kinase inhibitors that have attracted a lot of attention and excitement within the medicinal chemistry community and the general field of medicine," said Mark Cushman, a distinguished professor of medicinal chemistry in Purdue's College of Pharmacy, who leads the research team. "Our compounds contribute a new structural chemotype that is expected to have unique pharmacological properties relative to the other known Janus kinase inhibitors."
![Exfoliative Dermatitis]( "Exfoliative Dermatitis")
Exfoliative dermatitis or erythroderma is a skin condition where the skin becomes reddened and inflamed accompanied by severe itching and peeling of the skin.
Cushman, a member of the Purdue University Center for Cancer Research, said the new molecules also show potential to allow for more treatment options for people with autoimmune diseases. Abnormalities of the immune system often lead to autoimmune diseases or cancer.
The work aligns with Purdue's Giant Leaps celebration, celebrating the university's global advancements in health as part of Purdue's 150th anniversary. This is one of the four themes of the yearlong celebration's Ideas Festival, designed to showcase Purdue as an intellectual center solving real-world issues.
Researchers filed a patent with the Purdue Office of Technology Commercialization and the technology is available for licensing.
Source: Eurekalert
Exfoliative Dermatitis
Exfoliative dermatitis or erythroderma is a skin condition where the skin becomes reddened and inflamed accompanied by severe itching and peeling of the skin.
Advertisement
Cushman, a member of the Purdue University Center for Cancer Research, said the new molecules also show potential to allow for more treatment options for people with autoimmune diseases. Abnormalities of the immune system often lead to autoimmune diseases or cancer.
The work aligns with Purdue's Giant Leaps celebration, celebrating the university's global advancements in health as part of Purdue's 150th anniversary. This is one of the four themes of the yearlong celebration's Ideas Festival, designed to showcase Purdue as an intellectual center solving real-world issues.
Researchers filed a patent with the Purdue Office of Technology Commercialization and the technology is available for licensing.
Source: Eurekalert
Pemphigus
Pemphigus is a rare group of autoimmune diseases that affect the skin and mucous membranes causing blisters and sores that fail to heal.
Advertisement
 PsoriasisPsoriasis is a recurrent and complex inflammatory skin disorder that can have tremendous physical and psychological impact on the sufferer | Advertisement
|
Advertisement
Recommended Reading
Latest Research News
Brain plasticity following blindness leads to superior ability in sensing signals from the heart, which has implications for bodily awareness and emotional processing.
A group of scientists were awarded £1.3 million to create a new “point of care testing” kit that detects Alzheimer's disease biomarkers.
Is there a connection between Osteoporosis and dementia? Yes, loss in bone density may be linked to an increased risk of dementia in older age.
Link between chromosome length and biological aging marker discovered. The finding helps explain why people with longer telomeres have a lower dementia risk.
Integrated structural biology helps discover how the cystic fibrosis transmembrane conductance regulator (CFTR) works.